Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 32 Neoplasms 26 Depression 21 Fatigue 20 Prostatic Neoplasms 13 Lymphoma, Follicular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Multiple Myeloma 11 Lymphoma, Large B-Cell, Diffuse 10 Lung Neoplasms 10 Colorectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Pain 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Hodgkin Disease 9 Burkitt Lymphoma 9 Anxiety Disorders 9 Vomiting 7 Nausea 7 Leukemia, Myeloid, Acute 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Head and Neck Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Blast Crisis 7

Interventions

HhAntag691 18 Imiquimod 10 sonidegib 8 Photochemotherapy 7 1-phenyl-3,3-dimethyltriazene 6 methyl 5-aminolevulinate 4 Surgical Procedures, Operative 4 Biopsy 4 Aminolevulinic Acid 4 cemiplimab 3 Mohs Surgery 3 Microscopy, Confocal 3 Itraconazole 3 IPI-926 3 3-ingenyl angelate 3 tazarotene 2 Microarray Analysis 2 Laser Therapy 2 Gene Expression Profiling 2 Eflornithine 2 Drug Evaluation 2 Acitretin 2 tozuleristide 1 teriflunomide 1 talimogene laherparepvec 1 silmitasertib 1 remetinostat 1 pembrolizumab 1 gusacitinib 1 green tea extract polyphenone E 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Basal Cell × Therapeutics × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡